Taisie Seigrist, a 15-year-old track and cross-country athlete in Oklahoma, was diagnosed with Type 1 diabetes five years ago ...

After years of managing type 1 diabetes with mealtime insulin shots, 15-year-old Taisie Seigrist says the FDA’s recent ...

The FDA has approved inhaled insulin, Afrezza, for children 6 and older, giving doctors and families a new tool to manage ...

Backed by phase 3 INHALE-1 data, the expanded indication provides a noninvasive, needle-free mealtime insulin alternative for children and adolescents.

Millions of people around the world live with diabetes mellitus. Many of them have medication and specific dietary management approaches to help them maintain stable blood sugar levels. However, ...

Inhaled insulin (Afrezza; MannKind Corporation) continues to build a case for broader adoption in pediatric diabetes care. After its FDA approval for children aged 6 and older in May 2026, new data ...

CINCINNATI (WXIX) - Cincinnati Children’s Hospital is among the first facilities in the country to use inhalable insulin, which could be a fast-acting breakthrough for diabetes patients. Cincinnati ...

Most of the 38 million people living with diabetes in the U.S. use daily injections or insulin pumps to keep glucose at safe levels — but new research suggests that a third option could be just as ...

Mannkind Corporation expects to submit a request for a supplemental new drug application meeting to the US Food and Drug Administration for its inhaled human insulin (Afrezza Inhalation Powder).

The U.S. Food and Drug Administration has approved Afrezza (insulin human) Inhalation Powder for use in children and ...

Perhaps clashing with our apparently unabashed anti-LIFE sentiment, we present to you word of an inhaled form of insulin, due out within a year. The device would work by using dry powder insulin from ...

The pulmonary delivery of insulin may reduce the need for multiple daily subcutaneous injections of insulin for many patients with diabetes. The lungs are an attractive site for delivery of insulin ...